FMR LLC lifted its position in Vertex by 2.5% in the third quarter. FMR LLC now owns 2,287,774 shares of the company’s stock valued at $88,102,000 after acquiring an additional 54,985 shares ...

David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. The Motley Fool has a disclosure policy.

Here's why they think Eli Lilly (NYSE: LLY), Summit Therapeutics (NASDAQ: SMMT), and Vertex Pharmaceuticals (NASDAQ: VRTX) could trounce the market in 2025. David Jagielski (Eli Lilly): For years ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

A police spokesman said the mother and the baby, a girl, had been brought to Bellevue Hospital in stable condition. Ms. Saint Pierre’s older sister, Stephania Saint Pierre, confirmed the mother ...

What is Planet Position in Astrology? Planet position is a diagrammatic representation of the condition and positions of the celestial bodies at any given time for any given location on Earth. Planet ...